Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Molecular Profile Hints at Inflammatory Processes in Chronic Fatigue

Lisa Rapaport  |  August 2, 2017

(Reuters Health)—People with severe symptoms of chronic fatigue syndrome have a molecular signature in blood made up of 17 immune system signaling molecules that are elevated, which may provide insight into how inflammation contributes to the condition. “Of the 17 cytokines that correlated with severity, 13 are proinflammatory, likely contributing to many of the symptoms…

More Than a Third of U.S. Adults Prescribed Opioids in 2015

Andrew M. Seaman  |  August 2, 2017

(Reuters Health)—The U.S. needs to curb excessive opioid prescribing and improve access to pain management techniques, suggests a new government study. Researchers found that more than one third of U.S. adults were prescribed the medications in 2015 and many also misused the drugs. “A very large proportion and large number of adults use these medications…

Insurers to Fill Obamacare Gaps in Ohio’s Individual Market

Reuters Staff  |  August 2, 2017

(Reuters)—Five health insurance companies in Ohio, including Molina Healthcare Inc., have stepped up to sell health plans in 19 counties that would have been without Obamacare individual coverage in 2018, the state’s insurance regulator said on Monday.1 Ohio’s Department of Insurance said it had worked to draw in insurers for the 20 counties that were…

Trump Aims at Insurers in Battle Over Healthcare Subsidies

Susan Heavey & Caroline Humer  |  August 1, 2017

WASHINGTON/NEW YORK (Reuters)—U.S. President Donald Trump on Monday took aim at the nation’s health insurers in an escalating threat to cut the healthcare subsidy payments that make Obamacare plans affordable, one day after urging Republican senators to continue working to undo his Democratic predecessor’s healthcare law. “If ObamaCare is hurting people, and it is, why…

Online Risk Calculator for Knee OA Influences Patient Risk Perception

Arthritis Care & Research  |  August 1, 2017

A new tool for assessing the risk of developing knee osteoarthritis (OA) may be useful for knee OA education. A recent study found the online risk calculator, OA Risk C, was effective in helping patients better understand their personal risk of developing the disease. It may also motivate some patients to embrace exercise-related behavior changes…

Abatacept Approved for Adult PsA

Michele B. Kaufman, PharmD, BCGP  |  July 31, 2017

The FDA has approved abatacept to treat adults with active psoriatic arthritis. In clinical trials, the treatment has proved effective in both intravenous and subcutaneous forms…

Genetic Analysis Provides Insights into How Human Growth Is Linked to OA

Lara C. Pullen, PhD  |  July 31, 2017

Research has shed light on the genetic mutations that link GDF5 with arthritis and height. An ancient regulatory variant in GROW1 has been repeatedly selected in humans in northern environments, explaining the high frequency of a GDF5 haplotype that increases arthritis susceptibility…

Guidelines on Advice for Low Back Pain at Odds with Clinical Trial Results

Reuters Staff  |  July 30, 2017

NEW YORK (Reuters Health)—Advice is considered an effective treatment for acute low back pain (LBP), but neither clinical trials nor guidelines include adequate detail on what this advice should be, or how doctors should deliver it, according to a new review. And half of the advice topics included in guidelines were discordant with evidence from…

U.S. House Panel Spotlights Use of FDA Rules to Slow Generic Drugs

Diane Bartz  |  July 28, 2017

WASHINGTON (Reuters)—Republican and Democratic lawmakers on Thursday discussed ways to prevent drugmakers from using rules developed to safeguard patients to instead block the sale of cheaper medicines. The focus at a hearing, held by members of the House Judiciary Committee’s antitrust subcommittee, was on the use by some brand name drug companies of a U.S….

Republican Bid to Gut Obamacare Fails in Senate

Yasmeen Abutaleb, Amanda Becker & David Morgan  |  July 28, 2017

WASHINGTON (Reuters)—A U.S. Senate led by Donald Trump’s fellow Republicans dealt the president a harsh blow on Friday, failing to move ahead with a major campaign promise to dismantle Obamacare as they fell one vote short of passing healthcare legislation. Three senators—John McCain (R-Az.), Susan Collins (R-ME) and Lisa Murkowski (R-Ala.)—joined Senate Democrats in the…

  • « Previous Page
  • 1
  • …
  • 409
  • 410
  • 411
  • 412
  • 413
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences